Decoy Therapeutics Inc. (DCOY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.75M |
| Enterprise Value | -6.96M |
| P/E Ratio | -0.1 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.36 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.47 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.61 |
| Return On Equity | -3.15 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -8.52M |
| EBITDA | -12.51M |
| Net Income | -12.52M |
| Diluted EPS | -25.99 |
| Total Cash | 8.29M |
| Total Cash/Share | 15.58 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.83 |
| Book Value Per Share | 8.12 |
| 52-Week Change | -94.88 |
| 52-Week High | 70.8 |
| 52-Week Low | 2.85 |
| Moving Average 50 Days | 4.73 |
| Moving Average 200 Days | 7.07 |
| Average Volume | 249,746 |
| Shares Outstanding | 531,968 |
| % Held by Institutions | 0.3 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | March 09, 2026 |